Heart Rate Variability (HRV): Normal Ranges vs. Functional Optimal Targets

What Heart Rate Variability Actually Measures

HRV quantifies the variation in time intervals between consecutive heartbeats, called R-R intervals or NN intervals. A healthy heart does not beat like a metronome. It constantly adjusts timing in response to breathing, posture, temperature, and stress. This variability reflects the push-and-pull between the sympathetic ("fight or flight") and parasympathetic ("rest and digest") branches of the autonomic nervous system 1.

The 1996 Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology established the measurement standards still used today. That document defined two categories of HRV metrics: time-domain measures (like SDNN and RMSSD) and frequency-domain measures (like low-frequency and high-frequency power) 1. Time-domain metrics dominate clinical and consumer reporting because they are simpler to compute and less sensitive to recording artifacts.

SDNN is the standard deviation of all normal R-R intervals over a recording period, typically 24 hours. It captures total autonomic variability. RMSSD (root mean square of successive differences) reflects beat-to-beat changes and tracks parasympathetic tone specifically 2. Most wearable devices report RMSSD because it is reliable even with short recording windows of 1 to 5 minutes.

Lab-Normal Ranges: Where the Numbers Come From

Standard HRV reference ranges are derived from population-level studies that include both healthy individuals and people with subclinical disease. That distinction matters. The "normal" band is wide enough to contain someone with excellent cardiovascular fitness and someone silently progressing toward heart failure.

For 24-hour SDNN, the Task Force identified values below 50 ms as "unhealthy" and values between 100 and 180 ms as typical for healthy adults 1. The ARIC (Atherosclerosis Risk in Communities) study, which followed 11,654 adults for 7.6 years, found that those in the lowest quartile of HRV had a 32% higher risk of cardiac events compared to those in the highest quartile 3. A 24-hour SDNN below 70 ms carried the highest risk.

Short-term RMSSD "normal" values are harder to pin down because they vary enormously by age, sex, recording time, and body position. A 2017 review by Shaffer and Ginsberg reported pooled healthy-adult RMSSD means of 42 ms (seated, 5-minute recording), with a standard deviation of roughly 15 to 20 ms 2. For clinical practice, many labs consider an RMSSD between 20 and 80 ms as the reference range for adults aged 20 to 60.

The problem: that floor of 20 ms is already associated with elevated sympathetic tone. Being "normal" at 22 ms does not mean your autonomic nervous system is functioning well.

Functional Optimal Targets: A Different Standard

Functional or "optimal" HRV targets aim to identify the range associated with the lowest disease risk, best recovery capacity, and strongest correlation with healthy aging. These targets typically correspond to the upper two quartiles (50th to 90th percentile) of age- and sex-matched healthy populations.

The distinction follows a pattern familiar from other biomarkers. Fasting glucose of 99 mg/dL is "normal" but a functional medicine practitioner would flag anything above 85 mg/dL. HRV follows the same logic. Dr. Fred Shaffer, a professor of psychology at Truman State University and co-author of a widely cited HRV overview, has written: "Optimal HRV is associated with a profile of health, self-regulatory capacity, and adaptability, while reduced HRV is a marker of decreased physiological flexibility" 2.

Practical functional optimal benchmarks based on published population data look roughly like this:

RMSSD (short-term, supine, morning measurement):

• Ages 20 to 29: above 45 ms
• Ages 30 to 39: above 35 ms
• Ages 40 to 49: above 28 ms
• Ages 50 to 59: above 22 ms
• Ages 60+: above 18 ms

24-hour SDNN:

• Adults under 60: above 120 ms
• Adults 60 to 75: above 100 ms

These numbers draw on normative data from the Framingham Heart Study cohort 4 and European population studies published through 2023 5. They are not diagnostic cutoffs. They are targets that track with lower cardiovascular and all-cause mortality across multiple longitudinal studies.

Why the Gap Between Normal and Optimal Matters

A patient can sit squarely in the "normal" range and still carry meaningful autonomic dysfunction. The MPIP (Multicenter Post-Infarction Program) study demonstrated this clearly: among 808 post-MI survivors, those with 24-hour SDNN <50 ms had 5.3 times the mortality risk compared to those with SDNN above 100 ms over 31 months of follow-up 6. Even patients with SDNN between 50 and 100 ms, which many labs would call "low-normal," had 2.1 times the risk.

The clinical takeaway is direct. Dr. George Billman, professor emeritus of physiology at Ohio State University, stated in a 2011 review: "Reduced heart rate variability has been shown to be a powerful and independent predictor of adverse prognosis in patients with heart disease and in apparently healthy populations" 7.

For individuals using HRV as a wellness or training metric, the gap matters differently. A morning RMSSD of 25 ms in a 35-year-old man is technically normal. It also places him in the bottom 30th percentile for his age and sex, suggesting chronic sympathetic dominance, poor recovery, or both. A functional optimal perspective would flag this for further investigation into sleep quality, stress burden, alcohol intake, or undiagnosed conditions like sleep apnea.

HRV Declines with Age, and That Is Partly Modifiable

HRV decreases with age. This is among the most consistent findings in autonomic physiology. Data from the Framingham Heart Study show an approximate 1% annual decline in SDNN starting in the mid-20s 4. By age 60, average SDNN values are roughly 30 to 40% lower than at age 25.

Some of that decline is biological and inevitable. Arterial stiffening, reduced baroreceptor sensitivity, and age-related changes in the sinoatrial node all contribute 8. But a significant portion of age-related HRV decline is modifiable. Cross-sectional studies consistently show that physically active older adults have HRV profiles 10 to 15 years "younger" than sedentary age-matched peers 9.

This is why age-adjusted benchmarks matter. Comparing a 55-year-old's RMSSD to a 25-year-old's creates false alarm. Comparing a 55-year-old's RMSSD to the top quartile of healthy 55-year-olds provides actionable information about whether there is room for improvement through lifestyle intervention.

How to Raise HRV: Evidence-Based Strategies

Raising HRV means shifting autonomic balance toward greater parasympathetic tone and overall autonomic flexibility. Three interventions have the strongest evidence.

Aerobic exercise is the single most powerful modulator of resting HRV. A 2019 meta-analysis of 81 studies (N=3,141) found that aerobic training increased RMSSD by a mean of 4.8 ms and SDNN by 6.7 ms over 4 to 24 weeks of training 10. The effect was dose-dependent: moderate-intensity training (3 to 5 sessions per week, 30 to 60 minutes) produced the most consistent gains. High-intensity interval training showed larger acute post-exercise HRV suppression but comparable chronic improvements.

Sleep optimization directly impacts overnight HRV. A 2020 study of 52,000 Oura ring users found that each additional hour of sleep (up to approximately 8 hours) was associated with a 5 to 8 ms increase in overnight RMSSD 11. Sleep fragmentation (frequent awakenings) reduced HRV independently of total sleep time. Treating obstructive sleep apnea with CPAP has been shown to increase 24-hour SDNN by 10 to 15 ms within 3 months 12.

Slow-paced breathing at approximately 6 breaths per minute maximizes respiratory sinus arrhythmia, the natural HRV fluctuation linked to breathing. A 2019 systematic review of 15 studies found that daily slow-breathing practice for 4 to 12 weeks increased resting RMSSD by 3 to 9 ms 13. The mechanism involves direct vagal stimulation through the baroreflex loop.

Other supported but less robustly studied interventions include limiting alcohol intake (even moderate drinking suppresses overnight HRV by 10 to 20%), omega-3 fatty acid supplementation (modest SDNN increases of 3 to 5 ms in trials), and stress management through cognitive behavioral techniques 14.

When High HRV Is Not a Good Sign

The assumption that higher HRV is always better is mostly correct but has exceptions. Extremely high HRV can indicate pathological states.

Atrial fibrillation produces dramatically irregular R-R intervals that inflate HRV metrics artificially. If a wearable suddenly reports an RMSSD spike above 200 ms, atrial fibrillation should be considered rather than celebrated 15. Some algorithms filter for this, but many consumer devices do not.

Overtraining syndrome can present with paradoxically elevated resting HRV alongside fatigue, mood disturbance, and declining performance. The mechanism is thought to involve excessive parasympathetic rebound as the body attempts to compensate for chronic stress 16. This pattern, high HRV combined with poor subjective recovery, is a warning sign that training load needs reduction.

Bradyarrhythmias, including high-grade AV block, can also artificially inflate certain HRV metrics due to irregular ventricular timing. Clinical context always matters more than a single number.

When Low HRV Deserves Medical Attention

Not every low HRV reading warrants concern. A single poor night of sleep, an acute illness, or a hard training session the previous day can temporarily suppress RMSSD by 30 to 50%. Trend data over weeks tells the real story.

Persistent low HRV (consistently below the 25th percentile for age and sex over several weeks of clean recordings) warrants clinical evaluation. Conditions associated with chronically reduced HRV include:

• Heart failure: SDNN <70 ms is an independent predictor of mortality in heart failure patients 6
• Diabetes: Both type 1 and type 2 diabetes reduce HRV early in the disease course, often before clinical autonomic neuropathy is apparent. A 2003 meta-analysis found diabetic patients had 25 to 40% lower SDNN compared to controls 17
• Depression and anxiety: Major depressive disorder is associated with reduced vagal tone. A meta-analysis of 36 studies found that depressed individuals had significantly lower RMSSD (effect size d = 0.34) compared to healthy controls 18
• Obstructive sleep apnea: Repeated hypoxic episodes and arousal suppress parasympathetic tone. Severity of apnea (measured by AHI) correlates inversely with nocturnal HRV 12

If a patient presents with low HRV and no obvious lifestyle explanation, screening for these conditions is clinically appropriate.

Wearable HRV vs. Clinical-Grade HRV

Consumer wearables (Apple Watch, Oura, Whoop, Garmin) have democratized HRV tracking. The accuracy question is now well studied.

A 2022 validation study compared Oura Ring Gen 3 HRV measurements against simultaneous Holter monitor recordings in 30 subjects. The correlation coefficient for RMSSD was r = 0.98, with a mean absolute error of 4.2 ms 19. Apple Watch showed similar correlations (r = 0.91 to 0.96) in separate validation work 20.

The caveat: wearables typically record HRV during a single window (overnight or a brief morning session) rather than a full 24-hour Holter. This means wearable-derived HRV values should not be compared directly to 24-hour SDNN reference ranges. Wearable RMSSD should be interpreted against short-term, position-matched normative data.

For clinical decision-making (post-MI risk stratification, diabetic autonomic neuropathy staging, heart failure prognosis), a formal 24-hour Holter recording remains the standard. For trend monitoring, lifestyle optimization, and early detection of autonomic shifts, wearables provide clinically meaningful data at a fraction of the cost.

Putting It Together: A Practical Interpretation Framework

Reading an HRV result requires context. A single number means little. The same RMSSD of 35 ms could be excellent for a 65-year-old woman or concerning for a 28-year-old male endurance athlete. Four variables shape interpretation:

1. Age and sex: Always use age- and sex-matched percentile rankings rather than absolute cutoffs
2. Recording conditions: Supine, seated, or standing HRV values differ by 20 to 40%. Morning values before rising are the most reproducible
3. Trend direction: A 15% decline in 7-day average RMSSD is more meaningful than any single-day reading
4. Clinical context: Medications (beta-blockers raise HRV; anticholinergics lower it), caffeine timing, and acute illness all shift the baseline

The goal is not to chase a specific number. The goal is to track your individual trend against your own baseline, then compare your baseline to age-matched functional optimal targets to determine whether autonomic function could benefit from intervention.

Patients whose HRV sits in the bottom quartile persistently, despite adequate sleep, regular exercise, and controlled stress, should discuss formal autonomic testing with their physician. Those in the 50th to 90th percentile range for their age group can use HRV as a day-to-day recovery and readiness metric, adjusting training intensity and stress management practices based on short-term fluctuations.